glp-1 rebound weight gain on Ozempic: Biomarkers & Response – PlexusDx What Happens after You Quit

Obesity-related chronic conditions like type 2 and kidney disease are among the top culprits of this disparity ( source )

Some medical conditions and medications contribute to weight gain or make weight management more challenging

Those with good outcomes may be overrepresented

All three peptides discussed here ultimately increase GH and IGF-1 levels, thereby promoting benefits such as muscle growth, fat loss, tissue repair, immune support, and improved recovery

Some of the arguments being used include that Novo Nordisk failed to properly warn patients of Ozempics risks, created a defective drug, misrepresented the product when marketing it to the public, and was negligent in its actions